Bacterial meningitis is a severe infection responsible for high mortality. This prospective study of 277 pediatric bacterial meningitis cases was done to identify factors predicting death in children <16 years of age living and treated in a limited-resources country (Kosovo). Of the 277 children enrolled, 60 patients (22%) developed neurologic complications, and 15 children died (5%). The following variables were strongly correlated with mortality: altered mental status on admission (relative risk [RR] = 29.9), presentation of the initial cerebrospinal fluid as thick pus (RR = 29.9), prehospital seizures (RR = 23.5) and their recurrence >24 hours after admission (RR = 11.5), age <1 month (RR = 19.3), the use of inotropic agents (RR = 11.5), and admission after 5 days’ duration of illness (P < .001). The mortality rate in children in Kosovo is similar to those reported from developing countries, and this is most likely due to the unfavorable living conditions.
Chávez-BuenoSMcCrackenGHJr. Bacterial meningitis in children. Pediatr Clin North Am. 2005;52:795–810.
2.
DurandMLCalderwoodSBWeberDJ. Acute bacterial meningitis in adults: a review of 493 episodes. N Eng J Med. 1993;328(1):21–28.
3.
GrimwoodKAndersonPAndersonVTanLNolanT.Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child. 2000;83:111–116.
4.
McIntyrePBMacIntyreCRGilmourRWangH.A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Arch Dis Child. 2005;90:391–396.
5.
ØstergaardCKonradsenHBSamuelssonS.Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection. BMC Infect Dis. 2005;5:93.
6.
KilpiTPeltolaHJauhiainenTKallioMJ.Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. Pediatr Infect Dis J. 1995;14:270–278.
7.
PerezAEDickinsonFORodrigezM.Community acquired bacterial meningitis in Cuba: a follow up of a decade. BMC Infect Dis. 2010;10:130.
8.
QuagliarelloVJScheldWM.Treatment of bacterial meningitis. N Eng J Med. 2003;336:708–716.
9.
van de BeekDde GansJSpanjaardL. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351:1849–1859.
10.
Saez-LlorensXMcCrackenGH.Bacterial meningitis in children. Lancet. 2003;361:2139–2148.
11.
Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children: United States, 1998-2000. MMWR Morb Mortal Wkly Rep. 2002;51:234–239.
12.
TheodoridouMNVasilopoulouVAAtsaliEE. Meningitis registry of hospitalized cases in children: epidemiological patterns of acute bacterial meningitis throughout a 32-year period. BMC Infect Dis. 2007;7:101.
13.
BaraffLJLeeSISchrigerDL.Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis. J. 1993;12:389–394.
14.
KaplanSLWoodsC.Neurologic complications of bacterial meningitis in children. Curr Clin Top Infect Dis. 1992;12:37–55.
15.
KaplanSLCatlinFIWeaverTFeiginRD.Onset of hearing loss in children with bacterial meningitis. Pediatrics. 1984;73:575–578.
16.
TaylorHGMillsELCiampiA. The sequelae of Haemophilus influenzae meningitis in school-age children. N Engl J Med. 1990;323:1657–1663.
17.
OostenbrinkRMaasMMoonsKGMollHA. Sequelae after bacterial meningitis in childhood. Scand J Infect Dis. 2002;34:379–382.
18.
De JongeRCJVan FurthAMWassenaarM. Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies. BMC Infect Dis. 2010;10:232.
19.
AkpedeGOAkuhwaRTOgijiEOAmbeJP.Risk factors for an adverse outcome in bacterial meningitis in the tropics: a reappraisal with focus on the significance and risk of seizures. Ann Trop Paediatr. 1999;19:151–159.
20.
AroninSIPeduzziPQuagliarelloVJ.Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med. 1998;129:862–869.
21.
GrimwoodKNolanTMBondL. Risk factors for adverse outcomes of bacterial meningitis. J Paediatr Child Health. 1996;32:457–462.
22.
BohrVHansenBJessenO. Eight hundred and seventy-five cases of bacterial meningitis. Part I of a three-part series: clinical data, prognosis, and the role of specialized hospital departments. J Infect. 1983;7:21–30.
23.
KlingerGChinCNBeyeneJPerlmanM.Predicting the outcome of neonatal bacterial meningitis. Pediatrics. 2000;106:477–482.
24.
LebelMHMcCrackenGHJr. Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children. Pediatrics. 1989;83:161–167.
25.
LindbergJRosenhallUNylenORingnérA.Long-term outcome of Haemophilus influenzae meningitis related to antibiotic treatment. Pediatrics. 1977;60(1):1–6.
26.
StrangJRPughEJ.Meningococcal infections: reducing the case fatality rate by giving penicillin before admission to hospital. Br Med J. 1992;305:141–143.
27.
TsaiMHChenSHHsuCY. Pneumococcal meningitis in Taiwanese children: emphasis on clinical outcomes and prognostic factors. J Trop Pediatr. 2008;54(6):390–394.
28.
PelkonenTRoineIMonteiroL. Risk factors for death and severe neurological sequelae in childhood bacterial meningitis in sub-Saharan Africa. Clin Infect Dis. 2009;48(8):1107–1110.
29.
SchuchatARobinsonKWengerJD. Bacterial meningitis in the United States in 1995: active surveillance team. N Engl J Med. 1997;337:970–976.
30.
SpanjaardLBolPde JongMCZanenHC.Bacterial meningitis in 366 children in the Netherlands, 1982-1983: epidemiology and antibiotic therapy. J Antimicrob Chemother. 1986;54:1–8.
31.
KimKHSohnYMKangJH. The causative organisms of bacterial meningitis in Korean children, 1986-1995. J Korean Med Sci. 1998;13:60–64.
32.
AdegbolaRASeckaOLahaiG. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunization with a Hib conjugate vaccine: a prospective study. Lancet. 2005;366:144–150.
33.
CowgillKDNdirituMNyiroJ. Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA. 2006;296:671–678.
34.
PeltolaH.Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000;13:302–317.
35.
MolyneuxEMWalshALForsythH. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomized controlled trial. Lancet. 2002;360:211–218.
36.
PaglianoPFuscoUAttanasioV. Pneumococcal meningitis in childhood: a longitudinal prospective study. FEMS Immunol Med Microbiol. 2007;51:488–495.
37.
SchaadUBLipsUGnehmHE. Dexamethasone therapy for bacterial meningitis in children. Lancet. 1993;342:457–461.
38.
WengerJDHightowerAWFacklamRR. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis. 1986;162:1316–1323.
39.
De LouvoisJBlackbournJHurleyRHarveyD.Infantile meningitis in England and Wales: a two year study. Arch Dis Child. 1991;66:603–607.
40.
GirgisNIFaridZMikhailIA. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J. 1989;8:848–851.
41.
KennedyWAHoytMJMcCrackenGHJr. The role of corticosteroid therapy in children with pneumococcal meningitis. Am J Dis Child. 1991;145:1374–1378.
42.
OdioCMFaingezichtIParisM. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med. 1991;324:1525–1531.
43.
WaldERKaplanSLMasonEOJr. Dexamethasone therapy for children with bacterial meningitis. Pediatrics. 1995;95:21–28.
44.
van de BeekDFarrarJJde GansJ. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol. 2010;9(3):254–263.
45.
KimKHLeeHChungEH. Immunogenicity and safety of two different Haemophilus influenzae type b conjugate vaccines in Korean infants. J Korean Med Sci. 2008;23:929–936.
